Seeking Alpha

Shares of Alkermes (ALKS -0.4%) fail to get a spark from todays buying, largely due to Credit...

Shares of Alkermes (ALKS -0.4%) fail to get a spark from todays buying, largely due to Credit Suisse initiating the stock with a tepid Neutral rating and lackluster $24 price target. The firm says ALKS has an enticing long-term story, but its recent run (the stock is already +21% YTD versus +7% for its peers) leaves the broker looking for a better entry point. Additionally, a potentially negative readout for its depression drug candidate ALKS 5461 poses near-term risks.
Comments (1)
  • a great company with huge long term potential.

     

    if you are a long term investor looking for big profits, go with the tide and not short term ripples in the water.

     

    former long term early holder of genentech, amgen,etc.
    18 Jan 2013, 12:32 AM Reply Like
DJIA (DIA) S&P 500 (SPY)